Tremor
Parkinson's Disease
search
Parkinson's Disease
, Parkinsonism, Parkinsons Disease, Parkinson Disease
See Also
Tremor
Rest Tremor
Parkinsonism Management
Carbidopa/Levodopa
(
Sinemet
)
Dopamine Agonist
Toxin-Induced Parkinsonism
Atypical Pakinsonism
Parkinson's Disease Resources
Epidemiology
Onset after age 50 years
New diagnoses: 60,000 per year in U.S.
Prevalence
(U.S.)
Overall: 0.3%
Age over 60 years: 1%
Age over 80 years: 4%
Associated with positive
Family History
in >25% cases
More common in men
Pathophysiology
Slow degeneration of
Substantia Nigra
(within the
Basal Ganglia
) of the
Midbrain
Dopamine
rgic
Neuron
s degenerate in the nigrostriatal pathway
Nigrostriatal pathway regulates movement initiation and control
Dopamine
rgic
Neuron
s from the
Substantia Nigra
are inhibitory at the caudate and
Putamen
Parkinsonism results in loss of these inhibitory
Neuron
s
Allows for uncountered excitatory
Cholinergic Activity
at the caudate and
Putamen
Antiparkinsonism medications act primarily in 2 ways
Increase
Dopamine
neurotransmission (e.g.
Carbidopa-Levodopa
)
Decrease
Cholinergic
neurotransmission (e.g.
Benztropine
)
Degeneration progressively effects extrapyramidal systems
Start in
Substantia Nigra
pars compacta
Continue via Striatum to
Globus Pallidus
Basal Ganglia
project to cortex
Lewy bodies accumulate in residual
Dopamine
Neuron
s
Lewy bodies are not specific to Parkinsonism (associated with many neurodegenerative diseases)
Ascending process (Lower
Brainstem
affected first)
Step 1:
Medulla
and later,
Pons
affected
REM Sleep
disorder
Depression
Dysautonomia
Olfactory deficits
Step 2:
Midbrain
and later basal forebrain affected
Parkinsonian motor symptoms
Step 3: Prefrontal cortex and ultimately neocortex affected diffusely
Dementia
Causes
Parkinsonism
Primary Parkinsonism
Parkinson's Disease (idiopathic, onset in midlle age or older)
Secondary Parkinsonism
Vascular Parkinsonism (Multi-infarct, atherosclerotic disease)
Wilson's Disease
Normal Pressure Hydrocephalus
Chronic
Trauma
tic encephalopathy (Punch Drunk Syndrome,
Dementia
pugilistica, Boxer's
Dementia
)
Huntington's Disease
Basal Ganglia
tumors (rare)
Post-
Encephalitis
(rare)
Neurotoxin
s - Permanent
Manganese Dust
Tetrahydropyridine (MPTP)
Neurotoxin
s - Transient
Dopamine
Antagonist
s (e.g.
Chlorpromazine
,
Haloperidol
,
Metoclopramide
)
Reserpine
Symptoms
Prodromal
Non-specific symptoms may precede motor symptoms and
Tremor
by 20 years
Non-specific symptoms
Hyposmia
Constipation
Fatigue
References
Hawkes (2010) Parkinsonism Relat Disord 16(2): 79-84 [PubMed]
Signs
Bradykinesia
(PPV >4 when combined with rigidity)
Smaller handwriting (micrographia) (PPV 2.8)
Masklike stare (flat or masked facial expressions)
Infrequent blink
Slowed walking and dressing
Soft Voice trails off
Difficult manual dexterity
Difficulty opening jars (PPV 6.1)
Difficulty rolling over in bed (PPV 13)
Impaired gait and mobility
Change in stride
Poor Heel to toe gait (
Tandem Walk
ing) (PPV 2.9)
Short, shuffling steps (PPV 3.3)
Festinating gait (involuntary gait acceleration)
Parkinsonism
Gait
Video
https://www.youtube.com/watch?v=pFLC9C-xH8E
Postural Instability
Imbalance while walking or standing
Frequent falls
Stooping forward to maintain center of gravity
Resting
Tremor
(primarily, although also displays
Action Tremor
as well)
Hands and feet considerably affected
Begins as low frequency, pill-rolling finger motion, typically unilateral
Progresses to involve
Forearm
pronation and supination
Then involves elbow flexion and extension
Also affects head, face, lips,
Tongue
, jaw and neck
Regular Rhythm (3-6 beats/sec)
Tremor
onset at rest and better with voluntary movement
Presenting Symptom in 50-75% of Parkinson's patients
Tremor
absent in up to 20% of Parkinson's Disease
Resting
Tremor
video
https://www.youtube.com/watch?v=7uhT2ipQpKs
Pill Rolling
Tremor
video
https://www.youtube.com/watch?v=e532YW-Zwf0
Rigidity (PPV >4 with
Bradykinesia
)
Onset on same side of body with
Tremor
May alter gait and
Posture
, and result in myalgias
May affect breathing, eating,
Swallowing
, and speech
Cogwheel rigidity (ratchet-like limb movement)
Lead-pipe rigidity (uncommon, rigid throughout passive motion)
Freezing of movement (sudden, transient motor blocks)
Secondary Effects
Akathisia
Cognitive Impairment
Depressed Mood
Fatigue
Impotence
Increased
Saliva
tion
Orthostatic Hypotension
,
Paroxysmal drenching sweats
Seborrheic Dermatitis
Urinary Frequency
Constipation
Decreased olfaction
REM Sleep
Disorder
References
Rao (2003) JAMA 289:347-53 [PubMed]
Diagnosis
Criteria
Response to
Levodopa
or
Dopamine Agonist
challenge and
Classic symptoms and signs
Distal resting
Tremor
at 3-6 beats per second (Hz)
Rigidity
Bradykinesia
Asymmetric and gradual onset
Parkinsonism usually presents with one limb affected more than others
Common pitfall in missed diagnosis is ruling-out Parkinsonism based on asymmetry
Diagnosis
Findings that suggest alternative diagnosis
Poor
Levodopa
response
Falls in the early stages of disease
Symmetric involvement at onset
Rapid progression
Absent
Tremor
Hallucination
s
Prominent and early
Dementia
Early postural instability
Severe and early
Autonomic Dysfunction
Upward
Gaze Paralysis
Involuntary movements beyond
Tremor
Suchowersky (2006) Neurology 66(7): 968-75 [PubMed]
Differential Diagnosis
Secondary Parkinsonism and Other Alternative Diagnoses
See
Atypical Pakinsonism
Dementia with Lewy Bodies
Resting
Tremor
often absent in
Lewy Body Dementia
Prominent
Visual Hallucination
s and signficant fluctuations in attention and cognition
Poor response to
Carbidopa/Levodopa
Drug Induced Parkinsonism:
Dopamine
blocking drugs
Metoclopramide
(
Reglan
)
Reserpine
Antipsychotic
(e.g.
Haloperidol
,
Risperidone
)
Toxin-Induced Parkinsonism
See
Toxin-Induced Parkinsonism
See
Drug-Induced Tremor
Vascular Parkinsonism
Occurs in
Cerebrovascular Disease
(TIA, CVA) in step-wise progression with each vascular event
Refractory to
Carbidopa/Levodopa
Focal neurologic deficits may be present
Basal Ganglia
or thalamic infarctions on
CT Head
or
MRI Brain
Structural lesions
Cortical degeneration
Brainstem Infarction
Multiple system atrophy (e.g. Shy-Drager syndrome)
Progressive Supranuclear Palsy
Hydrocephalus
Normal Pressure Hydrocephalus
Atypical Pakinsonism
See
Atypical Pakinsonism
Essential Tremor
Symmetric
Postural Tremor
of the distal extremities, head and voice
Worse with movement and better with
Alcohol
,
Beta Blocker
s
Miscellaneous causes
CNS Infection
Other
Tremor
Rest Tremor
Differential Diagnosis
Based on specific findings
Stiff and slow without
Tremor
(seen in >20% of Parkinsonism)
Progressive supranuclear palsy
Isolated
Tremor
Essential Tremor
Drug-Induced Tremor
(e.g.
Wellbutrin
,
Valproic Acid
)
Tremor
of entire hand
Essential Tremor
Cerebellar disorder
Bradykinesia
and gait change
Advanced age
Vascular Parkinsonism
Dementia
With mild
Bradykinesia
:
Alzheimer's Disease
With
Hallucination
s:
Lewy Body Dementia
With
Incontinence
:
Normal Pressure Hydrocephalus
Prominent autonomic symptoms
Shy-Drager Syndrome
Imaging
SPECT Imaging (1231-FP-CIT SPECT or DaTSCAN)
Consider in unclear cases of Parkinsonism to differentiate from other causes
Visualizes integrity of CNS
Dopamine
rgic pathways
Vlaar (2007) BMC Neurol 7:27 [PubMed]
MRI Head
or
CT Head
Not routinely indicated
Order if atypical presentation (see above)
Evaluates for alternative diagnosis (e.g. progressive supranuclear palsy)
Transcranial
Ultrasonography
Bartova (2014) Ultrasound Med Biol 40(10): 2365-71 [PubMed]
Management
See
Parkinsonism Management
See
Carbidopa/Levodopa
(
Sinemet
)
See
Dopamine Agonist
Prognosis
Disability
and need for ADL assistance at 3 to 7 years after disease onset
Poor outcome within 10 years of disease onset in 77% of patients
Postural instability
Death
Dementia
Predictors of rapid progression
Advanced age at diagnosis
Badykinesia or rigidity at time of diagnosis
In contrast, prominent
Tremor
is associated with slower progression
Complications
Dementia
(40%)
Psychosis
(20-40%, esp.
Hallucination
s, paranoid
Delusion
s)
References
Ahlskog (2011) Mayo Internal Medicine Review Lecture
Schim (2001) CMEA Medicine Lecture, San Diego
Clarke (2003) Clin Evid 10:1582-98 [PubMed]
Clarke (2004) Lancet Neurol 3:466-74 [PubMed]
Gazewood (2013) Am Fam Physician 87(4): 267-73 [PubMed]
Halli-Tierney (2020) Amf fam Physician 102(11):679-91 [PubMed]
Nutt (2005) N Engl J Med 353:1021-7 [PubMed]
Olanow (2001) Neurology 56:S1-88 [PubMed]
Rao (2006) Am Fam Physician 74:2046-56 [PubMed]
Young (1999) Am Fam Physician 59(8):2155-67 [PubMed]
Type your search phrase here